Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

5articles mentioning diseases

8disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: LupusQoL ×

LupusQoL

This disease is selected. Its supporting articles are shown below.

Articles mentioning LupusQoL

5 articles · page 1 of 1

PO:13:334 Grip strength, dexterity, and activities of daily living are independent predictors of poor quality of life in people living with systemic lupus erythematosus

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

81.5%

Systemic Lupus Erythematosus SLE LupusQoL medications Purdue

…Objectives Patients with Systemic Lupus Erythematosus (SLE) often experience impaired health-related quality of life …

PO:13:343 Associations of lifestyle features with quality of life in patients with systemic lupus erythematosus. Results from baseline clinical data of the multi-omic multi-institutional SMILES study

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

94.0%

SLE LupusQoL lupus Rheumatology departments

…ting physical activity and health education as part of holistic SLE care.…

PO:13:336 Improvement of fatigue, musculoskeletal pain, morning stiffness and health-related quality of life in patients with SLE treated with dapirolizumab pegol: 48-week results from a phase 3 trial

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

80.6%

SLE SLE-specific Lupus LupusQoL Dapirolizumab pegol NCT04294667 DZP prednisone

…raphics and disease characteristicsConclusions In patients with SLE, DZP+SOC treatment was associated with benefits in fatigue, mus…

PO:13:342 Do diet habits influence the quality of life of patients with systemic lupus erythematosus? Results from baseline clinical data of the multi-omic multi-institutional SMILES study

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

91.9%

LupusQoL lupus SLE

… consumption of sweets and cold cuts. QoL was measured with the LupusQoL across eight domains: physical health, pain, planning, intimate…

PT7:02 Discordance between SLEDAI-2K and BILAG-2004 disease activity classification leads to divergent treatment decisions under EULAR 2023 recommendations: a post-hoc analysis of anifrolumab trials

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

83.8%

SLE lupus SLE-DAS LupusQoL anifrolumab BILAG-2004 AstraZeneca EQ-5D SLEDAI-2K SLEDAI

…ifrolumab trials (MUSE, TULIP-1, TULIP-2) in moderate-to-severe SLE. Physicians’ assessments (clinical and laboratory data, BILAG-2…